Keloid & Hypertrophic Scars
Summary
Keloid and hypertrophic scars are forms of abnormal wound healing characterised by excessive collagen deposition. Hypertrophic scars are raised, red, and itchy but remain within the boundaries of the original wound and typically regress over time. Keloid scars extend beyond the original wound margins (like "claws"), do not regress spontaneously, and have a very high recurrence rate after excision. Keloids are more common in individuals of Afro-Caribbean descent and typically occur at high-tension sites (earlobes, sternum, shoulders). Treatment includes intralesional steroids (first-line for keloids), silicone sheets, and pressure therapy.
Key Facts
- Hypertrophic: Stays WITHIN wound boundaries; often regresses over 1-2 years
- Keloid: Extends BEYOND wound boundaries ("claws"); does NOT regress
- Risk Factors: Afro-Caribbean skin, high-tension sites (sternum, shoulder, earlobe)
- Treatment (Keloid): Intralesional steroids (Triamcinolone) is gold standard
- Treatment (Hypertrophic): Silicone gel sheets, pressure garments
- Recurrence: Keloid excision has 50-100% recurrence unless combined with adjuvant therapy
Clinical Pearls
"Within = Hypertrophic, Beyond = Keloid": The key distinction is whether the scar stays within the original wound (hypertrophic) or grows beyond it (keloid).
"Keloids Love Ear Lobes": Ear lobes are a classic site for keloids after piercing. Also sternum, shoulders, and upper back.
"Don't Just Excise Keloids": Excision alone has 50-100% recurrence. Always combine with intralesional steroids or radiotherapy.
"Steroids Are First-Line": Intralesional triamcinolone is the gold standard for keloids - flattens the scar by inhibiting collagen synthesis.
Incidence
- Hypertrophic scars: Common (up to 70% after burns)
- Keloids: 4-16% in higher-risk populations
Demographics
- Afro-Caribbean: 15x higher keloid risk than Caucasians
- Asian and Hispanic: Intermediate risk
- Peak age: 10-30 years
- Rare in elderly and very young
High-Risk Sites
| Site | Risk Level |
|---|---|
| Ear lobes | Very high (piercing) |
| Sternum | High |
| Shoulders | High |
| Upper back | High |
| Deltoid | High |
Risk Factors
| Factor | Notes |
|---|---|
| Afro-Caribbean ethnicity | Strongest risk factor |
| Family history | Genetic component |
| Age 10-30 | Peak incidence |
| High-tension wounds | Sternum, shoulder |
| Delayed wound healing | Infection, poor closure |
Normal Wound Healing
- Haemostasis
- Inflammation
- Proliferation (fibroblasts, collagen)
- Remodelling (collagen maturation, scar flattening)
Abnormal Scar Formation
| Feature | Hypertrophic | Keloid |
|---|---|---|
| Collagen | Type III predominates | Type I and III (disorganised) |
| Myofibroblasts | Present | Present |
| TGF-β | Elevated | Markedly elevated |
| Apoptosis | Normal | Decreased (fibroblasts persist) |
Why Keloids Don't Regress
- Decreased fibroblast apoptosis
- Persistent TGF-β signalling
- Ongoing collagen synthesis
- No remodelling phase
Hypertrophic Scar
| Feature | Description |
|---|---|
| Shape | Raised, stays within wound |
| Colour | Red/pink initially, fades |
| Symptoms | Itchy, may be tender |
| Timeline | Develops within 4-8 weeks; regresses over 1-2 years |
Keloid Scar
| Feature | Description |
|---|---|
| Shape | Extends beyond wound ("claw-like") |
| Colour | Pink, red, or hyperpigmented |
| Symptoms | Pruritus, pain, tenderness |
| Timeline | May develop months-years after injury; does NOT regress |
Common Triggers
Inspection
- Raised, firm scar
- Check if extends beyond original wound edges (keloid)
- Colour (red/pink or hyperpigmented)
Palpation
- Firm, rubbery texture
- Non-tender to mildly tender
Distribution
- High-tension areas (chest, shoulder, ear)
- Check for multiple scars (recurrence, keloid tendency)
Clinical Diagnosis
- Usually clinical based on history and appearance
- Biopsy rarely needed (unless atypical)
Histology (If Biopsied)
- Dense collagen bundles
- Increased fibroblasts
- Keloid: Thick hyalinised collagen ("keloidal collagen")
Treatment Ladder
┌──────────────────────────────────────────────────────────┐
│ KELOID & HYPERTROPHIC SCAR MANAGEMENT │
├──────────────────────────────────────────────────────────┤
│ │
│ HYPERTROPHIC SCAR: │
│ • Silicone gel sheets (12+ hours/day for months) │
│ • Pressure garments (burns) │
│ • Massage │
│ • Intralesional steroids (if refractory) │
│ • Pulsed dye laser │
│ → Often regress spontaneously over 1-2 years │
│ │
│ KELOID SCAR: │
│ • Intralesional STEROIDS (Triamcinolone 10-40mg/mL) │
│ - Injections every 4-6 weeks │
│ - Gold standard first-line treatment │
│ • Silicone gel sheets (adjunct) │
│ • Cryotherapy (small keloids) │
│ • Excision + adjuvant therapy: │
│ - Intralesional steroids post-op │
│ - Radiotherapy (within 24-48h) │
│ • 5-Fluorouracil (intralesional; off-label) │
│ • Pressure earrings (ear lobes) │
│ │
│ ⚠️ SURGERY ALONE = 50-100% RECURRENCE │
│ │
└──────────────────────────────────────────────────────────┘
Intralesional Steroids
- Triamcinolone acetonide 10-40 mg/mL
- Inject directly into keloid (not subcutaneously)
- Repeat every 4-6 weeks
- Side effects: Skin atrophy, hypopigmentation, telangiectasia
Prevention
- Avoid unnecessary procedures in keloid-prone individuals
- Tension-free wound closure
- Silicone sheets early post-surgery
Of Scars
- Cosmetic disfigurement
- Pruritus and pain
- Functional impairment (contracture if over joints)
- Psychological distress
Of Treatment
- Steroid: Atrophy, hypopigmentation, telangiectasia
- Surgery: Recurrence (high for keloids)
- Radiotherapy: Theoretical malignancy risk (very low)
Hypertrophic Scars
- Usually regress over 12-24 months
- Good response to silicone and pressure
Keloids
- Do NOT regress spontaneously
- Recurrence rate 50-100% after excision alone
- Better outcomes with combined therapy (excision + steroids/radiotherapy)
Key Guidelines
- British Association of Dermatologists: Keloid Guidelines
- International Scar Guidelines
Key Evidence
Intralesional Steroids
- 50-100% response rate for keloids
- Best when combined with other modalities
Silicone
- Meta-analyses support efficacy for prevention and treatment
What Are Keloids and Hypertrophic Scars?
When wounds heal, a scar forms. Sometimes the scar grows more than normal:
- Hypertrophic scar: A raised, red scar that stays within the wound area and usually flattens over time.
- Keloid: A scar that grows beyond the original wound, like spreading fingers. It doesn't go away on its own.
Who Gets Them?
Keloids are much more common in people with darker skin, especially those of African, Asian, or Hispanic heritage. Ear lobes, chest, and shoulders are common sites.
How Are They Treated?
- Steroid injections into the scar are the main treatment for keloids
- Silicone sheets/gel worn over the scar can help
- Surgery may be needed but has high recurrence - usually combined with steroid injections or radiotherapy
Can They Be Prevented?
If you're prone to keloids, avoid unnecessary piercings or surgeries. After any wound or surgery, silicone gel and pressure therapy may help prevent abnormal scarring.
Primary Guidelines
- British Association of Dermatologists. Patient Information: Keloid Scars.
Key Studies
- Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3):606. PMID: 28282841